Genomtec S.A. Logo

Genomtec S.A.

Develops mobile platforms for rapid, point-of-care molecular diagnostics.

GMT | WAR

Overview

Corporate Details

ISIN(s):
PLGNMTC00017
LEI:
259400ND13Y44ADMG554
Country:
Poland
Address:
WROCŁAW BIERUTOWSKA 57-59, 51-317 WROCŁAW

Description

Genomtec S.A. is a technology company specializing in the development of mobile platforms for rapid molecular diagnostics. The company's flagship product is Genomtec ID, a portable point-of-care system for genetic testing that combines the amplification and detection of specific DNA and RNA fragments. This technology enables fast and accurate analysis without requiring specialized laboratory infrastructure or personnel. A key application is the CE-IVD certified GenomtecID Respiratory Panel 5-Plex (RP5-PLEX), which detects viruses and bacteria causing respiratory tract infections. The company has also organized its core technologies, the Genomtec ID platform and the OncoSNAAT oncology project, into separate special purpose vehicles to facilitate strategic development and potential M&A processes.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-10-28 18:12
5._Klauzula_informacyjna_RODO.pdf
Polish 131.4 KB
2022-10-28 18:12
4._Informacja_o_liczbie_akcji_i_glosow.pdf
Polish 75.2 KB
2022-10-28 18:12
3._Formularz_glosowania_przez_pelnomocnika.pdf
Polish 119.7 KB
2022-10-28 18:12
2._Wzor_pelnomocnictwa.pdf
Polish 76.4 KB
2022-10-28 18:12
1._Projekty_uchwal_NWZA_2022.11.25.pdf
Polish 143.3 KB
2022-10-28 18:12
0._Ogloszenie_o_Zwolaniu_NWZA_na_dzien_25.11.2022.pdf
Polish 157.9 KB
2022-10-28 18:12
Zwołanie NWZA na dzień 25 listopada 2022 roku - Content (PL)
Polish 1.9 KB
2022-09-07 18:39
Rozpoczęcie przeglądu opcji strategicznych oraz podpisanie umowy na wykonanie o…
English 2.4 KB
2022-09-07 18:39
Rozpoczęcie przeglądu opcji strategicznych oraz podpisanie umowy na wykonanie o…
Polish 2.4 KB
2022-08-11 14:23
zalacznik
Polish 266.1 KB
2022-08-11 14:23
Zmiana stanu posiadania - Content (PL)
Polish 592 bytes
2022-08-10 16:15
zalacznik
Polish 1.0 MB
2022-08-10 16:15
Zmiana stanu posiadania - Content (PL)
Polish 591 bytes
2022-08-10 16:10
tresc zawiadomienia
Polish 177.2 KB
2022-08-10 16:10
Zmiana stanu posiadania - Content (PL)
Polish 591 bytes

Automate Your Workflow. Get a real-time feed of all Genomtec S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomtec S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomtec S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.